$Genprex (GNPX.US)$ This groundbreaking research represents a significant advancement in addressing one of oncology's most challenging problems: resistance to immunotherapy in non-small cell lung cancer. The study's findings are particularly compelling for several reasons: The demonstrated efficacy of NPRL2 gene therapy in anti-PD1 resistant cases is remarkable, especially considering that pembrolizumab (Keytruda®), a leading immunotherapy generating over 20 billion in ...
Genprex Stock Forum
This groundbreaking research represents a significant advancement in addressing one of oncology's most challenging problems: resistance to immunotherapy in non-small cell lung cancer. The study's findings are particularly compelling for several reasons:
The demonstrated efficacy of NPRL2 gene therapy in anti-PD1 resistant cases is remarkable, especially considering that pembrolizumab (Keytruda®), a leading immunotherapy generating over 20 billion in ...
Major Cancer Treatment Breakthrough: New Gene Therapy Defeats Drug-Resistant Lung Cancer
No comment yet